世界の嚢胞性線維症（ムコビスコイドーシス）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1698 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、嚢胞性線維症（ムコビスコイドーシス）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・嚢胞性線維症（ムコビスコイドーシス）検査の市場動向 ・企業の競争状況、市場シェア ・嚢胞性線維症（ムコビスコイドーシス）検査の種類別市場規模（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ） ・嚢胞性線維症（ムコビスコイドーシス）検査の用途別市場規模（病院、外来手術センター、その他） ・嚢胞性線維症（ムコビスコイドーシス）検査の北米市場規模2016-2027（アメリカ、カナダ） ・嚢胞性線維症（ムコビスコイドーシス）検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・嚢胞性線維症（ムコビスコイドーシス）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・嚢胞性線維症（ムコビスコイドーシス）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・嚢胞性線維症（ムコビスコイドーシス）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Vertex Pharmaceuticals、Abbott、Pfizer、NovaBiotics、Cystic Fibrosis Foundation、Galapagos） ・結論

Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.
Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.

Market Analysis and Insights: Global Cystic Fibrosis(Mucoviscoidosis)Testing Market
The global Cystic Fibrosis(Mucoviscoidosis)Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cystic Fibrosis(Mucoviscoidosis)Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cystic Fibrosis(Mucoviscoidosis)Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cystic Fibrosis(Mucoviscoidosis)Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cystic Fibrosis(Mucoviscoidosis)Testing market.

Global Cystic Fibrosis(Mucoviscoidosis)Testing Scope and Market Size
Cystic Fibrosis(Mucoviscoidosis)Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cystic Fibrosis(Mucoviscoidosis)Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chest Physical Therapy (CPT)
Consumption Of Antibiotics
Lung Transplant And Postural Drainage

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Vertex Pharmaceuticals
Abbott
Pfizer
NovaBiotics
Cystic Fibrosis Foundation
Galapagos

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chest Physical Therapy (CPT)
1.2.3 Consumption Of Antibiotics
1.2.4 Lung Transplant And Postural Drainage
1.3 Market by Application
1.3.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Perspective (2016-2027)
2.2 Cystic Fibrosis(Mucoviscoidosis)Testing Growth Trends by Regions
2.2.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cystic Fibrosis(Mucoviscoidosis)Testing Historic Market Share by Regions (2016-2021)
2.2.3 Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Regions (2022-2027)
2.3 Cystic Fibrosis(Mucoviscoidosis)Testing Industry Dynamic
2.3.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market Trends
2.3.2 Cystic Fibrosis(Mucoviscoidosis)Testing Market Drivers
2.3.3 Cystic Fibrosis(Mucoviscoidosis)Testing Market Challenges
2.3.4 Cystic Fibrosis(Mucoviscoidosis)Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Revenue
3.1.1 Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Revenue (2016-2021)
3.1.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Players (2016-2021)
3.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue
3.4 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Concentration Ratio
3.4.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in 2020
3.5 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis(Mucoviscoidosis)Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis(Mucoviscoidosis)Testing Breakdown Data by Type
4.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Historic Market Size by Type (2016-2021)
4.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Type (2022-2027)

5 Cystic Fibrosis(Mucoviscoidosis)Testing Breakdown Data by Application
5.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Historic Market Size by Application (2016-2021)
5.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2016-2027)
6.2 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type
6.2.1 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021)
6.2.2 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027)
6.2.3 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2027)
6.3 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application
6.3.1 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021)
6.3.2 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027)
6.3.3 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2027)
6.4 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country
6.4.1 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021)
6.4.2 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2016-2027)
7.2 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type
7.2.1 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021)
7.2.2 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027)
7.2.3 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2027)
7.3 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application
7.3.1 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021)
7.3.2 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027)
7.3.3 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2027)
7.4 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country
7.4.1 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021)
7.4.2 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2016-2027)
8.2 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type
8.2.1 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application
8.3.1 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Region
8.4.1 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2016-2027)
9.2 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type
9.2.1 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021)
9.2.2 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027)
9.2.3 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2027)
9.3 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application
9.3.1 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021)
9.3.2 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027)
9.3.3 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2027)
9.4 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country
9.4.1 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021)
9.4.2 Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2016-2027)
10.2 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type
10.2.1 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application
10.3.1 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country
10.4.1 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Details
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.2.4 Abbott Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.3.4 Pfizer Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 NovaBiotics
11.4.1 NovaBiotics Company Details
11.4.2 NovaBiotics Business Overview
11.4.3 NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.4.4 NovaBiotics Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.4.5 NovaBiotics Recent Development
11.5 Cystic Fibrosis Foundation
11.5.1 Cystic Fibrosis Foundation Company Details
11.5.2 Cystic Fibrosis Foundation Business Overview
11.5.3 Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.5.4 Cystic Fibrosis Foundation Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.5.5 Cystic Fibrosis Foundation Recent Development
11.6 Galapagos
11.6.1 Galapagos Company Details
11.6.2 Galapagos Business Overview
11.6.3 Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
11.6.4 Galapagos Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
11.6.5 Galapagos Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chest Physical Therapy (CPT)
Table 3. Key Players of Consumption Of Antibiotics
Table 4. Key Players of Lung Transplant And Postural Drainage
Table 5. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2016-2021)
Table 9. Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2022-2027)
Table 11. Cystic Fibrosis(Mucoviscoidosis)Testing Market Trends
Table 12. Cystic Fibrosis(Mucoviscoidosis)Testing Market Drivers
Table 13. Cystic Fibrosis(Mucoviscoidosis)Testing Market Challenges
Table 14. Cystic Fibrosis(Mucoviscoidosis)Testing Market Restraints
Table 15. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Players (2016-2021)
Table 17. Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing as of 2020)
Table 18. Ranking of Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Product Solution and Service
Table 22. Date of Enter into Cystic Fibrosis(Mucoviscoidosis)Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Vertex Pharmaceuticals Company Details
Table 63. Vertex Pharmaceuticals Business Overview
Table 64. Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 65. Vertex Pharmaceuticals Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 66. Vertex Pharmaceuticals Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 70. Abbott Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 75. Pfizer Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. NovaBiotics Company Details
Table 78. NovaBiotics Business Overview
Table 79. NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 80. NovaBiotics Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 81. NovaBiotics Recent Development
Table 82. Cystic Fibrosis Foundation Company Details
Table 83. Cystic Fibrosis Foundation Business Overview
Table 84. Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 85. Cystic Fibrosis Foundation Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 86. Cystic Fibrosis Foundation Recent Development
Table 87. Galapagos Company Details
Table 88. Galapagos Business Overview
Table 89. Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Product
Table 90. Galapagos Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021) & (US$ Million)
Table 91. Galapagos Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type: 2020 VS 2027
Figure 2. Chest Physical Therapy (CPT) Features
Figure 3. Consumption Of Antibiotics Features
Figure 4. Lung Transplant And Postural Drainage Features
Figure 5. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Cystic Fibrosis(Mucoviscoidosis)Testing Report Years Considered
Figure 10. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2022-2027)
Figure 14. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Players in 2020
Figure 15. Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in 2020
Figure 17. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2016-2027)
Figure 21. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2016-2027)
Figure 22. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Country (2016-2027)
Figure 23. United States Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2016-2027)
Figure 27. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2016-2027)
Figure 28. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Country (2016-2027)
Figure 29. Germany Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Region (2016-2027)
Figure 39. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2016-2027)
Figure 47. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2016-2027)
Figure 48. Latin America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Country (2016-2027)
Figure 49. Mexico Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Country (2016-2027)
Figure 55. Turkey Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 61. NovaBiotics Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 62. Cystic Fibrosis Foundation Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 63. Galapagos Revenue Growth Rate in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---